Nifedipine administered in pregnancy: effect on the development of children at 18 months

BJOG. 2000 Jun;107(6):792-4. doi: 10.1111/j.1471-0528.2000.tb13342.x.

Abstract

The safety of use of the calcium channel blocker nifedipine in pregnancy as it affects child development has not been well evaluated. We report the results, with regard to the safety for children of use of nifedipine in pregnancy, on children followed up at 18 months of age born from women recruited in a study comparing routine treatment with nifedipine compared with no treatment.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Calcium Channel Blockers / adverse effects*
  • Child Development / drug effects*
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertension / drug therapy
  • Infant
  • Nifedipine / adverse effects*
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / drug therapy
  • Prenatal Exposure Delayed Effects
  • Prognosis

Substances

  • Calcium Channel Blockers
  • Nifedipine